NASDAQ · Medical Devices · USD

Bruker Corporation (BRKRP) Stock Analysis

Bruker Corporation (BRKRP) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

BRKRP

$431.72

−$6.28 (−1.43%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BRKRP with… →

BRKRP Key Statistics

As of Sep 4, 2026

Trading

Open: $437.51
Previous Close: $438.00
Day's Range: 431.72–437.64
52-Week Range: 250.00–474.99
Volume: 1.70K
Beta: 1.26

Valuation

P/E Ratio: unprofitable

Financials (FY)

Revenue (FY): $3.44B+2.08%
Net Income (FY): −$8.60M−107.60%
Profit margin: −2.04%
1-Year Return: +78.72%

Dividend and dates

Dividend: $15.94+3.69%
Ex-Dividend Date: August 14, 2026
Avg Volume: 6.10K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BRKRP Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+20.98%
2025 (partial year)	+47.73%

As of September 4, 2026.

BRKRP Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$3.44B	−$8.60M	−0.3%
2024	$3.37B	$113.10M	3.4%
2023	$2.96B	$427.20M	14.4%
2022	$2.53B	$296.60M	11.7%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$3.44B	$1.58B	$236.00M	−$8.60M	−0.3%
2024	$3.37B	$1.65B	$379.20M	$113.10M	3.4%
2023	$2.96B	$1.51B	$489.10M	$427.20M	14.4%
2022	$2.53B	$1.31B	$462.40M	$296.60M	11.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BRKRP Dividend History

$3.68

Dividends per share, 2025 · 1 payments

Year	Dividends per share	Payments	Change
2026*	$11.96	3	—
2025	$3.68	1	—

Most recent payment: $3.99 per share, ex-dividend August 14, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BRKRP Valuation vs Medical Devices Median

Median of 151 stocks

Metric	BRKRP	Medical Devices median	vs median
Profit margin	−2.04%	−1.69%	0.3 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The record here covers Bruker Corporation, ticker BRKRP. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 11,085.

The most recent close on file for BRKRP is $431.72, dated September 4, 2026. That is −$6.28 (−1.43%) against the previous close. Over the past 52 weeks the price has ranged from $250.00 to $474.99. The latest close sits 72.69% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $3.44B. Against the prior fiscal year total of $3.37B, that is a change of +2.08%. The same year closed with a net loss of $8.60M. The reported profit margin is −2.04%. That is 0.3 percentage points below the Medical Devices median of −1.69%.

Across the 4 fiscal years on file, revenue moves from $2.53B in 2022 to $3.44B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Over the trailing twelve months the price has returned +78.72%. Beta against the wider market is reported at 1.26. Annualized volatility over the trailing 1 year is 48.32%.

Growth & Income

The trailing dividend yield is 3.69%. That is 2.3 percentage points above the Medical Devices median yield of 1.38%. The indicated annual rate is $15.94 a share. The ex-dividend date on file is August 14, 2026. Dividends are recorded for 2 calendar years; 2026 shows 3 payments totalling $11.96 a share. The year before, 2025, totalled $3.68 a share.

2026 is still running; the price is +20.98% year to date.

Peer Comparison

Bruker Corporation (BRKRP) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Bruker Corporation	BRKRP	—	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Bruker Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Visit website →